 |
Parkinsons News: 273 headlines |
|
|||||
Celebrity Fight Night Video  |
||||||||
|
||||||||
|
||||||||
| Sources used by our Parkinsons News Channel Research Team: | ||||||||
| The New York Times, CNN, FOX, CBS, BBC, Mayo Clinic, Johns Hopkins Medicine, UCLA Medical Center, National Institute of Health, Stanford Hospital, Memorial Sloan- Kettering, Yale Cancer Center, Massachusetts General Hospital, Brigham and Women's Hospital, University of Michigan, M. D. Anderson Cancer Center, National Institute of Health, American Cancer Association, NBC, Reuters News, American College of Cardiology, Journal of the American Medical Association & 100's more | ||||||||
| Links | ||||||||
| Barrow Neurological Institute | ||||||||
| Archives |
Friday
PharmaLive: Preliminary Study Shows Creatine and Minocycline May Warrant Further Study In Parkinson’s Disease
: "A National Institutes of Health sponsored clinical trial with 200 Parkinsons disease patients has shown that creatine and minocycline may warrant further consideration for study in a large trial, according to Karl Kieburtz, M.D., M.P.H., University of Rochester, who spoke today on behalf of the trial investigators at the World Parkinson Congress. Study investigators caution that while the news is encouraging, the results do not demonstrate that these agents are effective in Parkinsons disease. Before these interventions can be recommended as a treatment they must be tested in a larger trial with hundreds of patients. Study findings are available online and will be published in the March 14 issue of Neurology.*"
: "A National Institutes of Health sponsored clinical trial with 200 Parkinsons disease patients has shown that creatine and minocycline may warrant further consideration for study in a large trial, according to Karl Kieburtz, M.D., M.P.H., University of Rochester, who spoke today on behalf of the trial investigators at the World Parkinson Congress. Study investigators caution that while the news is encouraging, the results do not demonstrate that these agents are effective in Parkinsons disease. Before these interventions can be recommended as a treatment they must be tested in a larger trial with hundreds of patients. Study findings are available online and will be published in the March 14 issue of Neurology.*"